Pfizer lowers revenue forecast on strong dollar, supply issues

U.S. drugmaker Pfizer Inc cut the top end of its full-year revenue forecast range on Tuesday, citing a stronger dollar and lower revenue from its sterile-injections business.

Powered by WPeMatico

Scroll to top